Journal of Medical Virology

Article	Citations
Reconstruction of molecular evolution of human influenza A H1N1/2009 virus in Iran and neighboring countries	214
The potential rationale of COVID‐19 vaccine‐induced myopericarditis	167
Change in willingness to COVID‐19 vaccination in China: Two online surveys during the pandemic	142
	135
Unraveling the Role of Mutations Outside the Basal Promoter and Precore Regions in the HBeAg‐Negative Stage of Chronic Hepatitis B	117
Diversity of picornaviruses detected in diarrheal samples from children in Belém, Brazilian Amazon (1982–2019)	115
Serological responses to smallpox A33 antigen and monkeypox A35 antigen in healthy people and people living with HIV‐1 from Guangzhou, China	111
Cytomegalovirus seropositivity and its correlation with all‐cause mortality among US adults	111
Comment on “A systematic review and meta‐analysis of herpes zoster occurrence/recurrence after COVID‐19 infection and vaccination”	111
Molecular epidemiology of SARS‐CoV‐2 variants in circulation in the state of Maranhão, Brazil	109
Cytological features of human papillomavirus‐infected immature squamous metaplastic cells from cervical intraepithelial neoplasia grade 2	101
No signs of “tripledemic” in Finnish children	95
Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID‐19 booster dose in persons with HIV	93
Impact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg‐positive chronic hepatitis B	91
Epidemiological characteristics of norovirus infection in pediatric patients during the COVID‐19 pandemic	90
Real‐world effectiveness of sotrovimab and remdesivir for early treatment of high‐risk hospitalized COVID‐19 patients: A propensity score adjusted retrospective cohort study	88
Detection of SARS‐CoV‐2 virus in middle ear effusions and its association with otitis media with effusion	84
Seroprevalence of neutralizing antibodies against the respiratory syncytial virus in healthy adults in Guangzhou, southern China	81
Influenza vaccination on SARS‐CoV‐2 infection risk: A subgroup analysis on geographic factor	80
Inhibiting cardiac autophagy suppresses Zika virus replication	79
Cross‐sectional analysis reveals autoantibody signatures associated with COVID‐19 severity	77
IFN‐α2b Modulates GATA3 Expression to Inhibit Proliferation and Promote Apoptosis in KSHV‐Infected Cells	70
Vaccination Coverage Against Coronavirus Disease 2019 in People Living on Quilombos in Brazil and Its Association With the Human Development Index and the Quality of the Health System	70
SARS‐CoV‐2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID‐19 vaccine: Looking for correlates of protection	69
Comment on “The risk assessment of uveitis after COVID‐19 diagnosis”	68

Significant neutralizing escapes of Omicron and its sublineages in SARS‐CoV‐2‐infected individuals vaccinated with inactivated vaccines	68
Pexophagy Triggered by Enterovirus 71 Modulates the Production of Pro‐Inflammatory Cytokines Through Cholesterol Accumulation in Lysosomes	65
Establishment of nucleic acid sensing pathways‐based model in predicting response to immunotherapy and targeted drug in hepatitis virus‐related hepatocellular carcinoma	65
Prevalence of Human Herpesvirus 8 Infection in Patients With Type 2 Diabetes and Blood Donors	64
Outcomes of definitive local therapy with intensity‐modulated radiation therapy in elderly patients ≥70 years with HPV‐associated oropharyngeal cancer	64
Issue Information	62
Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patients	62
Novel diarylpyrimidine subtypes as HIV‐1 nonnucleoside reverse transcriptase inhibitors with improved resistance profile	62
SARS‐CoV‐2 ORF3a inhibits cGAS‐STING‐mediated autophagy flux and antiviral function	61
Highly sensitive and rapid detection of SARS‐CoV‐2 via a portable CRISPR‐Cas13a‐based lateral flow assay	61
Zoonotic spillover and extreme weather events drive the global outbreaks of airborne viral emerging infectious diseases	60
Association between cytomegalovirus seropositivity and all‐cause mortality: An original cohort study	58
Repurposing of the antibiotic nitroxoline for the treatment of mpox	57
Glycoprotein N Associations With Congenital Cytomegalovirus Infection and Neurological Sequelae	57
Human papillomavirus prevalence and genotype distribution in Liaocheng men between 2016 and 2022	57
Erratum	56
Effects of baloxavir and oseltamivir antiviral therapy on the transmission of seasonal influenza in China: A mathematical modeling analysis	56
Impact of Nonpharmaceutical Interventions During the COVID‐19 Pandemic on the Epidemiology and Seasonal Patterns of Acute Respiratory Infections in Children	55
Corrigendum	55
Correction to “Fullerene (C60 & C70)‐Meso‐Tris‐4‐Carboxyphenyl Porphyrin Dyads Inhibit Entry of Wild‐Type and Drug‐Resistant HIV‐1 Clades B and C”	55
Diagnostic Value of Epstein‐Barr Virus Immunofluorescence and Enzyme‐Immunoassay Platforms for Detecting IgA Antibodies in Nasopharyngeal Carcinoma in the Singaporean Cohort	54
Exploring the dynamics of the 2022 mpox outbreak in Canada	54
Geographic and Molecular Insights Into Bat Diversity and Virus Distribution in China: Implications for Public Health	50
A bivalent vaccine containing D614G and BA.1 spike trimer proteins or a BA.1 spike trimer protein booster shows broad neutralizing immunity	49
Estimating the Uptake of and Factors Associated With a New Vaccine Outside of the National Immunisation Programme: A Case Study of the EV‐A71 Vaccine Against Hand, Foot, and Mouth Disease	49
Integrated Phenotypic–Genotypic Surveillance of Neuraminidase Inhibitor Susceptibility in Influenza A(H1N1), A(H3N2), and B/Victoria Viruses in Saudi Arabia, 2024–2025	49
A Multicenter Clinical Evaluation of Polymerase Chain Reaction Coupled With Quantum Dot Fluorescence Analysis and Quantitative Real‐Time Reverse Transcription Polymerase Chain Reaction in the Diagnosi	49
Azvudine and nirmatrelvir–ritonavir in hospitalized patients with moderate‐to‐severe COVID‐19: Emulation of a randomized target trial	48
Enterovirus A71 Co‐Opts the IQGAP1 for a Non‐Lytic Release of Viral Particles	48
Rotavirus trends and distribution of genotypes before and during COVID‐19 pandemic era: Bangladesh, 2017–2021	48
SARS‐CoV‐2 seroprevalence and vaccine coverage from August to November 2021: A nationally representative survey in Mexico	48
Association of Torque Teno Virus With Corticosteroids, Rejection, and Infection in Adult and Pediatric Kidney Transplant Recipients	47
SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID‐19: The International Study of Inflammation in COVID‐19	47
Identification of a new polyomavirus in distinct human populations and tissues	47
Issue Information	46
	46
	46
ZNFX1 antisense RNA1 promotes antiviral innate immune responses via modulating ZNFX1 function	46
On coming back, the scaring COVID‐19 concern. Addressing indoor microclimates with innovative and straightforward solutions to prevent SARS‐CoV2 spreading	45
Pulmonary infection in patients with severe fever with thrombocytopenia syndrome: A multicentre observational study	45
Cardio–Renal Diseases Are Independent Risk Factors of Severe Human Metapneumovirus Infection Among Patients Without Chronic Airway Diseases	45
Cytomegalovirus‐RNA Accurately Identifies Clinically Significant Infection Needing Preemptive Therapy in Liver Transplanted Children: A Proof‐of‐Concept Study	45
Clinical Performance of OncoPredict HPV Screening Assay on Self‐Collected Vaginal and Urine Specimens Within the VALHUDES Framework	44
Cell Culture of a Swine Genotype 4 Hepatitis E Virus Strain	42
Neutralization of B.1.617.2 variant through antibodies elicited by ChAdOx1‐S, BBIBP‐CorV, and Gam‐COVID‐Vac in an Argentinean cohort	41
Circulating rotavirus P[8]‐lineage IV, unlike P[8]‐lineage III, significantly related to nonsecretors status in Iranian children	41
Serum extracellular vesicle‐derived ASS1 is a promising predictor for the occurrence of HEV‐ALF	41
Are bladder washing samples suitable for investigation of HPV infection in urinary bladder? Comparison in HPV prevalence between urine and washing samples	40
Efficient recall of SARS‐CoV‐2 variant‐reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters	40
Association of Remdesivir use with bradycardia: A systematic review and meta‐analysis	39

Ramsay Hunt syndrome and concurrent varicella‐zoster virus meningitis in Denmark: A nationwide cohort study	39
Development of a Next‐Generation Sequencing Protocol for Assessing Lenacapavir Resistance in HIV‐1 Capsid	39
Monkeypox Virus Subverts the Inflammatory Response of Macrophages at the Maternal‐Fetal Interface	39
COVID‐19 and Oncofertility: No SARS‐CoV‐2 in Semen but Inflammation Seems to Affect Sperm Parameters	39
BK Polyomavirus DNAemia With a High DNA Load Is Associated With De Novo Donor‐Specific HLA Antibodies in Kidney Transplant Recipients	38
Infection by SARS‐CoV‐2 with alternate frequencies of mRNA vaccine boosting	38
Posttranslational modifications of ACE2 protein: Implications for SARS‐CoV‐2 infection and beyond	38
Advanced technologies towards improved HPV diagnostics	38
Epidemiological Characteristics of Neuro‐Specific Antibodies Following Viral Infections	38
Increase of GII.17 Norovirus Infections During the 2024–2025 Season in Multiple Cities, China	38
RT‐RPA Assisted CRISPR/Cas12a Based One‐Pot Rapid and Visual Detection of the Pan‐Dengue Virus	37
Epidemiological and Clinical Characteristics of the Enterovirus D68 Outbreak in Spain in 2024	37
	36
Issue Information	36
Issue Information	36
An HBV‐Derived Peptide Poly6 as a Novel Candidate for Functional Cure Via IFN‐I–Mediated Epigenetic Regulation of cccDNA	36
Issue Information	36
Reflections Regarding Validation of New HPV Tests With Reduced HPV Genotypes: Report From an IARC Expert Consultation	36
Issue Information	35
Issue Information	35
Cytoplasmic Shift of Interferon Regulatory Factors Co‐Evolved With Jawed Vertebrate Innate Immunity	35
The impact of statin therapy on in‐hospital prognosis and endothelial function of patients at high‐to‐very high cardiovascular risk admitted for COVID‐19	34
Development and Validation of Amplicon‐Based Protocol for Sequencing of Respiratory Syncytial Virus Genome	34
Dynamic m 6 A profiles reveal the role of YTHDC2‐TLR2 signaling axis in Talaromyces marneffei infectio	34
Clinical Validation of the Venus HPV Full‐Genotyping Assay for Cervical Cancer Screening in the VALGENT‐4 Framework	34
IFI44 Functions as a Positive Regulator of Type I Interferon Signaling to Restrict Zika Virus Infection	34
Cover Image, Volume 95, Number 11, November 2023	34
Research progress in Fc‐effector functions against SARS‐CoV‐2	34
Lead Exposure and Humoral Immunity to Varicella Zoster Virus in the United States: A Nationwide Cross‐Sectional Study	34
Patterns of Co‐infection of HPV52 With Other HPV Genotypes and Their Risks of Cervical Precancer and Carcinoma	33
Small molecule RAF265 as an antiviral therapy acts against HSV‐1 by regulating cytoskeleton rearrangement and cellular translation machinery	33
The Emerging Roles of Alternative Splicing in Human Oncovirus Infection	33
The impact of cerebrospinal fluid viral polymerase chain reaction testing on the management of adults with viral meningitis: A multi‐center retrospective study	33
Influenza is more severe than our newest enemy (COVID‐19) in hospitalized children: Experience from a tertiary center	33
Infection pattern and immunological characteristics of Epstein‐Barr virus latent infection in cervical squamous cell carcinoma	33
Methodological Considerations in Evaluating Recombinant Zoster Vaccine Effectiveness in COPD Patients	32
Enhanced recombination among Omicron subvariants of SARS‐CoV‐2 contributes to viral immune escape	32
The human papillomavirus late life cycle and links to keratinocyte differentiation	32
Clinical performance of a newly developed domestic urine‐based HPV test for cervical cancer screening in China	32
Genome and proteomic analysis of risk factors for fatal outcome in children with severe community‐acquired pneumonia caused by human adenovirus 7	32
Assessment of antibody kinetics in mpox cases with indigenously developed IgM and IgG ELISA	32
Comparative efficacy and safety of nirmatrelvir/ritonavir and molnupiravir for COVID‐19: A systematic review and meta‐analysis	32
Complement Hyperactivation Is Mediated by Alternative and Lectin Pathways During Early Phase of Severe Vaccination‐Omicron BA.5 Infection	32
Changing spectrum and mortality disparities of etiology of liver cirrhosis in Beijing, China	31
Risks of alopecia areata in long COVID: Binational population‐based cohort studies from South Korea and Japan	31
Antibody Response Dynamics as an Early Predictor of Clinical Outcome in Severe Fever With Thrombocytopenia Syndrome (SFTS): A Retrospective Cohort Study for Prognostic Model Development	31
Deciphering head and neck cancer microenvironment: Single‐cell and spatial transcriptomics reveals human papillomavirus‐associated differences	31
Simple, sensitive, and visual detection of 12 respiratory pathogens with one‐pot‐RPA‐CRISPR/Cas12a assay	31
Hypertension is still a moving target in the context of COVID‐19 and post‐acute COVID‐19 syndrome	31
Differential diagnosis on measles and rubella discarded cases highlights a sharp increase in parvovirus B19 infections in Milan, Northern Italy, in the first months of 2024	31
Detection of Polish cases of highly virulent subtype B of HIV‐1 originating in the Netherlands	31
Two‐ and 3‐year outcomes in convalescent individuals with COVID‐19: A prospective cohort study	30
Prolonged viral shedding in an immunocompromised Korean patient infected with hMPXV, sub‐lineage B.1.3, with acquired drug resistant mutations during tecovirimat treatment	30
Assessment of the cobas® HBV RNA investigational assay in the setting of nucleoside analog therapy cessation	30
Immunoassay and mass cytometry revealed immunological profiles induced by inactivated BBIBP COVID‐19 vaccine	30
Sofosbuvir/Velpatasvir/Voxilaprevir Versus Sofosbuvir/Velpatasvir Plus Ribavirin in Patients With Hepatitis C Virus Genotype 3b and Compensated Cirrhosis: A Multicentre Randomized Controlled Trial	30
Viral metagenomics unveils MW (Malawi) polyomavirus infection in Brazilian pediatric patients with acute respiratory disease	30
Whole Genome Sequencing and Genetic Diversity of Respiratory Viruses Detected in Children With Acute Respiratory Infections: A One‐Year Cross‐Sectional Study in Senegal	29
Epidemiology and Genetic Surveillance of Human Hepatitis E Virus Infections in Shandong Province, Eastern China, 2019–2023	29
Reconstruction of the historic time course of blood‐borne virus contamination of clotting factor concentrates, 1974–1992	29
Association between influenza vaccination and one‐year all‐cause and cardiovascular mortality risk: A self‐controlled case series and matched case‐control study	29
Heterogeneous Evolution Among SARS‐CoV‐2 Genes and Variants of Concern	29
Evaluation of an E6/E7 PCR‐capillary electrophoresis fragment analysis in the genotyping of human papillomavirus in archival FFPE samples of oropharyngeal cancer	29
Analysis of ACE2 and TMPRSS2 coding variants as a risk factor for SARS‐CoV‐2 from 946 whole‐exome sequencing data in the Turkish population	28
Response to the Korea National Committee on Immunization Programs' Letter	28
Genomic epidemiology of the main SARS‐CoV‐2 variants in Italy between summer 2020 and winter 2021	28
Corrigendum	28
Hantaan Virus (HTNV) Human Infection on Jeju Island, South Korea: Unique Phylogeny and Epidemiology of HTNV	28
Rhinovirus persistence during the COVID‐19 pandemic—Impact on pediatric acute wheezing presentations	28
Mpox in Northeast Brazil: Spatiotemporal analysis and predictors associated with confirmed diagnosis	28
Differential avidity determination of IgG directed towards the receptor‐binding domain (RBD) of SARS‐CoV‐2 wild‐type and its variants in one assay: Rational tool for the assessment of protective immun	27
Phylogenetics and phylogeographic characteristics of coxsackievirus A16 in hand foot and mouth disease and herpangina cases collected in Beijing, China from 2019 to 2021	27
Omicron‐specific mRNA vaccine induced cross‐protective immunity against ancestral SARS‐CoV‐2 infection with low neutralizing antibodies	27
In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT‐qPCR assays for SARS‐CoV‐2 detection using whole genome sequencing	27
Resurgence of human metapneumovirus infection and influenza after three seasons of inactivity in the post‐COVID‐19 era in Hokkaido, Japan, 2022–2023	27
Consistency in human papillomavirus type detection between self‐collected vaginal specimens and physician‐sampled cervical specimens	27
Near full‐length genome analysis of HEV 4b subtype in pigs showed a similarity up to 99.944% compared to a patient in Guangdong province, China	27
Viral Interference and Coinfections: A Perspective From Hospital Surveillance of Respiratory Viruses	27
Associations of Lipid Profiles With the Onset of HEV‐Related Acute Liver Failure: A Multicenter Cohort Study	27
Measles in vulnerable populations: An outbreak in Roma settlements of Loire‐Atlantique, France, 2019	27

Safety of Low‐Dose Ibuprofen in Non‐Severe Dengue Patients for Managing Fever Is Consistent With Acetaminophen: A Retrospective Observational Study	27
Alcohol‐Induced Dendritic Cells and Their Exosomes Promote T‐Cell Immunity in Hepatitis B Virus Transgenic Mice and Patients With Chronic Hepatitis B	27
Modulation of Cell Cycle Kinases by Kaposi's Sarcoma‐Associated Herpesvirus	27
The signature of SARS‐CoV‐2 evolution reflects selective pressures within human guts	27
Cocirculation of A(H3N2) and B/Victoria increased morbidity in hospitalized patients in the 2019–2020 A(H1N1)pdm09 predominant influenza season in Israel	27
High pre‐Delta and early‐Omicron SARS‐CoV‐2 seroprevalence detected in dried blood samples from Kinshasa (D.R. Congo)	26
The resurgence of influenza A/H3N2 virus in Australia after the relaxation of COVID‐19 restrictions during the 2022 season	26
Incidences of new hepatitis B infection and anti‐hepatitis B core‐negative occult hepatitis B infection among Japanese blood donors in relation to anti‐hepatitis B surface antigen levels	26
The potential of PCNA inhibition as a therapeutic strategy in cervical cancer	26
Recombinant Zoster Vaccine Reduces All‐Cause Mortality, But Not Major Adverse Cardiovascular Events, in Patients With Immune‐Mediated Inflammatory Diseases Receiving Janus Kinase Inhibitors: A Large‐S	26
Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B	26
Systematic Reevaluation of Repurposed Drugs Against the Main Protease of SARS‐CoV‐2 via Combined Experiments	26
Comparison of intracellular cytokine staining versus an ELISA‐based assay to assess CMV‐specific cell‐mediated immunity in high‐risk kidney transplant recipients	26
Multikingdom characterization of gut microbiota in patients with rheumatoid arthritis and rheumatoid arthritis‐associated interstitial lung disease	25
Alterations in Cellular Gene Expression Due to Co‐Infection With Kaposi's Sarcoma‐Associated Herpesvirus and SARS‐CoV‐2: Implications for Disease Severity	25
A common mechanism links Epstein‐Barr virus infections and autoimmune diseases	25
Human Cytomegalovirus Replication Enhanced By Placental MicroRNAs	25
Whole‐genome sequencing of hMPXV1 in five Italian cases confirms the occurrence of the predominant epidemic lineage	25
Appearance of extrapyramidal symptoms in adolescent psychiatry patients during COVID‐19 infection	25
Comments on: Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV‐2 infection than negative patients and are associated to a worse outc	25
Comparison of the immunogenicity of nasal‐spray rVSV vector, adenovirus vector, and inactivated COVID‐19‐based vaccines in rodent models	25
Excess risk for acute myocardial infarction mortality during the COVID‐19 pandemic	25
HBV PreC interacts with SUV39H1 to induce viral replication by blocking the proteasomal degradation of viral polymerase	24
T cell epitopes are largely conserved in the SARS‐CoV‐2 Omicron subvariant (BA.1, BA.2, BA.3, and GKA)	24
DENV‐1 genotype V circulation during the nonepidemic period in the Northeast of São Paulo State endemic area	24
Remdesivir for the Treatment of Human Coronavirus OC43 Encephalitis	24
Development of a HEp2‐CDX Mouse Model With Sustained High RSV Viral Loads for Robust Antiviral Therapeutic Evaluation	24
Bilateral non‐necrotizing herpetic retinopathy: Unusual initial presentation of ocular HSV‐1 infection	24
Issue Information	24
Letter to the editor regarding the study on maternal HPV infection and the risk of congenital malformations	24
Monkeypox outbreak in Genoa, Italy: Clinical, laboratory, histopathologic features, management, and outcome of the infected patients	24
Issue Information	24
High‐Throughput Targeted Sequencing Identifies an HPV Methylation Panel for Detecting Cervical Lesion Progression	24
Changes in cerebrospinal fluid proteome of patients with tick‐borne encephalitis	24
Higher Expression of HPV16 Derived E7_LI Transcript Observed in Men With HIV and Recurrent Anal Cancer	24
The impact of cycling hypoxia on the phenotype of HPV‐positive cervical cancer cells	24
Evaluation of host cellular responses to Epstein–Barr virus (EBV) in adult lung transplant patients with EBV‐associated diseases	24
Regarding the article prevalence and impact of viral myocarditis in patients with severe fever with thrombocytopenia syndrome by Hao et al	24
Risks of cutaneous immune‐related adverse events in long COVID: Multinational cohort studies in South Korea, Japan, and the UK	23
Impact of heavy metals exposure on herpes simplex virus type I infection: A population‐based cross‐sectional study	23
Four conserved amino acids on human papillomavirus E6 predict clinical high‐risk types	23
The Association of RNase L, Cytokines, and Chemokines With Severity of Multisystem Inflammatory Syndrome in Children	23
Varicella‐Zoster Virus‐Specific Cell‐Mediated Immune Response Kinetics and Latent Viral Load Depending on Aging	23
Insights Into Kaposi Sarcoma‐Associated Herpesvirus‐Specific Humoral Responses	23
Recent history and biology of H5N1 influenza A virus infections of farm animals (poultry, goat, alpacas, dairy cattle, barn cats) and humans in the United States of America	23
Response to the Letter to the Editor on “Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS‐CoV‐2 Omicron infection”	23
Regaining virological suppression in a woman living with a six‐class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests	23
Oral Ad5 Vector‐Based SARS‐CoV‐2 Vaccine Effectively Induces Mucosal and Systemic Immune Responses in BALB/c Mice	23
SARS‐CoV‐2‐Induced PAPOLG Contributes to Inflammation Response by Stabilizing NF‐κB mRNA	23
Comparable CD8+ T‐cell responses to SARS‐CoV‐2 vaccination in single‐cell transcriptomics of recently allogeneic transplanted patients and healthy individuals	23
Comparing single versus multiple virus detection in pediatric acute gastroenteritis postimplementation of routine multiplex RT‐PCR diagnostic testing	23
Viral metagenomics enables accurate detection of viral pathogens in amniotic fluid samples from pregnant women with suspicion of congenital infection	23
Early recognition of a superinfection: This is the problem in the critically ill COVID‐19 patients	23
Clinical presentations of adult and pediatric SARS‐CoV‐2‐positive cases in a community cohort, Nashville, Tennessee	23
Rapid detection of Ebolavirus using isothermal recombinase‐aided amplification	23
A case of human buffalopox in Malappuram, India: The role of mpox surveillance in 2022	23
Two novel recombinant human mastadenovirus D genotypes associated with acute respiratory illness	23
Seroepidemiology study of rubella virus antibodies among neonates and pregnant women at hospitals in Henan province, China	23
Unexpected high incidence of parvovirus B19 nucleic acid detection in German blood donors in the winter/spring season 2023/2024	23
Genetic Conservation and Diversity of SARS‐CoV‐2 Envelope Gene Across Variants of Concern	22
Heterologous Versus Homologous COVID‐19 Boosters: Immune Response Outcomes in Renal Transplant Recipients	22
Early administration of Paxlovid reduces the viral elimination time in patients infected with SARS‐CoV‐2 Omicron variants	22
Vaccines for Covid‐19: An insight on their effectiveness and adverse effects	22
Correction to “Serum‐Derived Bovine Immunoglobulin Treatment in COVID‐19 Is Associated With Faster Resolution of Symptoms: A Randomized Pilot Clinical Trial”	22
A systematic review and meta‐analysis of herpes zoster occurrence/recurrence after COVID‐19 infection and vaccination	22
The burden of infectious diseases throughout and after the COVID‐19 pandemic (2020–2023) and Russo‐Ukrainian war migration	22
Rebound of Respiratory Virus Activity and Seasonality to Pre‐Pandemic Patterns	22
Omicron variant of SARS‐CoV‐2: A pandemic of global concern warrants a cautious approach	22
Risks of monkeypox virus infection in children	22
Estimating true prevalence through questionnaire data	22
Adenovirus‐Specific T Cells in Adults Are Frequent, Cross‐Reactive to Common Childhood Adenovirus Infections and Boosted by Adenovirus‐Vectored Vaccines	22
Erratum	22
Correction to “Safety and immunogenicity of COVID‐19 vaccination in patients with hepatocellular carcinoma (CHESS‐NMCID 2101): A multicenter prospective study”	22
Inside Back Cover Image, Volume 95, Number 1, January 2023	22
Synergy Effects of HPV E6‐E7 Encoding mRNA and Nucleic Acid Immunostimulators Improve Therapeutic Potential in TC‐1 Graft Tumor	22
A study on the morbid histopathological changes in COVID‐19 patients with or without comorbidities using minimally invasive tissue sampling	22
No health issue stands alone in Eastern Europe: Monkeypox emergence amidst socioeconomic and political crises	22
A 10‐year Retrospective Analysis on HPV Genotype Switching in a Tertiary Center in China: Infection Characterization and Clinical Outcome	22
Resurgence and Predominance of GII.17[P17] Norovirus in Children With Sporadic Acute Gastroenteritis in Shanghai, China	22
The pathophysiological and immunological background of the monkeypox virus infection: An update	22
Sequencing of monkeypox virus from infected patients reveals viral genomes with APOBEC3‐like editing, gene inactivation, and bacterial agents of skin superinfection	22
Transferrin Saturation Can Serve as a Novel Biomarker for Predicting the Occurrence and Development of BK Virus‐Related Nephropathy After Kidney Transplantation	21
Surveillance for SARS‐CoV‐2 and its variants in wastewater of tertiary care hospitals correlates with increasing case burden and outbreaks	21
Acute gastroenteritis outbreak associated with multiple and rare norovirus genotypes after storm events in Santa Catarina, Brazil	21
Endogenous HIV‐1 Tat Promotes Cell Proliferation, Migration, and Phagocytosis in Stably Infected Macrophages by Accumulating Lactate and Activating the Autophagy/MAPK Pathway	21
Change from low to out‐of‐season epidemics of influenza in China during the COVID‐19 pandemic: A time series study	21
Pan‐microscopic examination of monkeypox virus in trophoblasts cells reveals new insights into virions release through filopodia‐like projections	21
Non‐liver‐related mortality in the DAA era: Insights from post‐SVR patients with and without previous HCC history	21
A novel humanized tri‐receptor transgenic mouse model of HAdV infection and pathogenesis	21
Baicalin inhibits influenza A (H1N1)‐induced pyroptosis of lung alveolar epithelial cells via caspase‐3/GSDME pathway	21
Hepatitis B Virus Genomic Variability & HBV‐Related Disease Outcomes: A Molecular Epidemiology Perspective	21
Geriatric Nutritional Risk Index Plays Important Role in Predicting In‐Hospital Mortality in Patients With Severe Fever With Thrombocytopenia Syndrome: A Multi‐Center Observational Study	21
SARS‐CoV‐2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID‐19 due to Omicron BA.1 and BA.2	21
Regulation of autophagy by SARS‐CoV‐2: The multifunctional contributions of ORF3a	21
Enhanced Zika virus‐like particle development using Baculovirus spp. constructs	21